FDA Inspection 1068567 — CorneaGen
The FDA completed an inspection of CorneaGen on September 14, 2018 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 14, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Baltimore, MD (United States)